Skip to main content
Premium Trial:

Request an Annual Quote

Invitae, Outcomes4Me Collaborate to Improve Breast Cancer Genetic Testing Access

NEW YORK – Outcomes4Me, an oncology-focused mobile app developer, on Thursday said it is working with molecular testing firm Invitae to improve education and access to genetic testing for breast cancer patients and survivors.

Patients can currently order genetic testing to assess their cancer risk through Invitae, receive genetic counseling through Invitae's partner Genome Medical, and once test results are available, upload them to Outcomes4Me's app. The latest partnership will now allow patients to make a genetic counseling appointment and order testing directly from Outcomes4Me's platform. Patients can authorize Invitae to report test results directly to the Outcomes4Me platform, within which they can also create a clinical profile.

The results integration with the Outcomes4Me platform will improve users' access to evidence-based information on treatment options and clinical trial eligibility, and inform how updated treatment and testing guidelines might impact their care.

Studies have shown that the healthcare system is currently failing to identify a large swath of individuals who qualify for genetic cancer risk assessments based on current guidelines. According to Outcomes4Me's patient data, almost half of its users who qualified for testing based on the National Comprehensive Cancer Network's guidelines hadn't been tested or did not know if they had received testing.

The collaboration with Outcomes4Me supports Invitae's ongoing efforts to increase access to genetic testing. "By providing access to our comprehensive genetic testing and counseling services, Outcomes4Me is adding a valuable resource that will empower patients to advance their knowledge, understanding, and therefore, self-advocacy during treatment and survivorship," Ed Esplin, a clinical geneticist at Invitae, said in a statement.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.